Barclays Starts United Therapeutics Corp. (UTHR) at Equalweight
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $237.00 +1.08%
Rating Summary:
16 Buy, 9 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Rating Summary:
16 Buy, 9 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Join SI Premium – FREE
Barclays initiated coverage on United Therapeutics Corp. (NASDAQ: UTHR) with an Equalweight rating and a price target of $135.00.
For an analyst ratings summary and ratings history on United Therapeutics Corp. click here. For more ratings news on United Therapeutics Corp. click here.
Shares of United Therapeutics Corp. closed at $126.83 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Starts GE Vernova (GEV) at Neutral, 'Multiyear turnaround amid positive demand backdrop'
- B.Riley Resumes Taboola (TBLA) at Buy
- Craig-Hallum Assumes DiaMedica Therapeutics Inc. (DMAC) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
